Sweet Bee Venom Pharmacopuncture for Chemotherapy-Induced Peripheral Neuropathy

JAMS Journal of Acupuncture and Meridian Studies

Volumn 5, Issue 4, 2012, Pages 156-165

  Yoon, Jeungwon ^a   Jeon, Ju Hyun ^a   Lee, Yeon Weol ^a   Cho, Chong Kwan ^a   Kwon, Ki Rok ^b   Shin, Ji Eun ^c   Sagar, Stephen ^d   Wong, Raimond ^d   Yoo, Hwa Seung ^a  

^a Daejeon University   (South Korea)

^b Research Center of Pharmacopuncture Medicine Korean Pharmacopuncture Institute   (South Korea)

^c Chungnam National University   (South Korea)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Acupuncture; Chemotherapy induced peripheral neuropathy; Health related quality of life; Patient neurotoxicity questionnaire; Sweet bee venom pharmacopuncture; Visual analogue system; WHO CIPN grade

Indexed keywords

BEE VENOM;

ADULT; ARTICLE; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; PATIENT NEUROTOXICITY QUESTIONNAIRE; PERIPHERAL NEUROPATHY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUNCTURE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SWEET BEE VENOM PHARMACOPUNCTURE; TREATMENT DURATION; VISUAL ANALOG SCALE; WORLD HEALTH ORGANIZATION;

EID: 84865160058     PISSN: 20052901     EISSN: 20938152     Source Type: Journal    
DOI: 10.1016/j.jams.2012.05.003     Document Type: Article

References (57)

1. National Cancer Institute, NCI Cancer Bulletin. A closer look: chemotherapy-induced peripheral neuropathy. [accessed 05.22.12]. http://www.cancer.gov/aboutnci/ncicancerbulletin/archive/2010/022310/page6.
2. Wampler M, Rosenbaum E. Cancer supportive survivorship care, chemotherapy-induced peripheral neuropathy fact sheet. [accessed 05.22.12]. http://www.cancersupportivecare.com/nervepain.php.
3. HIV/AIDS Cancer Pain Release, WHO Pain & Palliative Care Communications Program. Neuropathic pain from chemotherapy in cancer: diagnosis & treatment dilemmas, an interview with Dr. Charles Loprinzi & Dr. Judy Paice. [accessed 05.22.12]. http://whocancerpain.wisc.edu/21_1+2.cipn.
4. Siegal T., Haim N. Cisplatin-induced peripheral neuropathy. Cancer 1990, 66:1117-1123.
5. Kautio A.-L., Haanpaa M., Saarto T., Kalso E. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Sympt Manage 2008, 35:31-39.
6. Rao R.D., Michalak J.C., Sloan J.A., Loprinzi C.L., Soori G.S., Nikcevich D.A., et al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebocontrolled, crossover trial (N00C3). Cancer 2007, 110:2110-2118.
7. Rao R.D., Flynn P.J., Sloan J.A., Wong G.Y., Novotny P., Johnson D.B., et al. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 2008, 112:2802-2808.
8. Barton D.L., Wos E.J., Qin R., Mattar B.I., Green N.B., Lanier K.S., et al. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer 2011, 19:833-841.
9. Bianchi G., Vitali G., Caraceni A., Ravaglia S., Capri G., Cundari S., et al. Symptomatic and neurophysiological responses of paclitaxel- or cisplatininduced neuropathy to oral acetyl-L-carnitine. Euro J Cancer 2005, 41:1746-1750.
10. Turning Point Women's Healthcare, Patient Guide to Chemotherapy Induced Peripheral Neuropathy (CIPN). [accessed 05.22.12]. http://www.myturningpoint.org/files/CIPN_Patient_Handout.pdf.
11. Tong Y., Guo H., Han B. Fifteen-day acupuncture treatment relieves diabetic peripheral neuropathy. J Acupunct Meridian Stud 2010, 3:95-103.
12. Zhang C., Ma Y.X., Yan Y. Clinical effects of acupuncture for diabetic peripheral neuropathy. J Tradit Chin Med 2010, 30:13-14.
13. Du J. The messengers from peripheral nervous system to central nervous system: involvement of neurotrophins and cytokines in the mechanisms of acupuncture. Zhen Ci Yan Jiu 2008 Feb, 33(1):37-40.
14. La J.L., Jaiali S., Shami S.A. Morphological studies on crushed sciatic nerve of rabbits with electroacupuncture or diclofenac sodium treatment. Am J Chin Med 2005, 33(4):663-669.
15. Chen Y.S., Yao C.H., Chen T.H., Lin J.G., Hsieh C.L., Lin C.C., et al. Effect of acupuncture stimulation on peripheral nerve regeneration using silicone rubber chambers. Am J Chin Med 2001, 29:377-385.
16. Schröder S., Liepert J., Remppis A., Greten J.H. Acupuncture treatment improves nerve conduction in peripheral neuropathy. Eur J Neurol 2007 Mar, 14(3):276-281.
17. Pomeranz B. Do endorphins mediate acupuncture analgesia?. Adv Biochem Psychopharmacol 1978, 18:351-359.
18. Pomeranz B., Chiu D. Naloxone blockade of acupuncture analgesia: endorphin implicated. Life Sci 1976, 19:1757-1762.
19. Han J.S. Acupuncture and endorphins. Neuro sci Lett 2004, 361(l-3):258-261.
20. Goldman N., Chen M., Fujita T., Xu Q., Peng W., Liu W., et al. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci 2010 Jul, 13(7):883-888.
21. Xu W.R., Hua B.J., Hou W., Bao Y.J. Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs. Zhongguo Zhen Jiu 2010 Jun, 30(6):457-460.
22. Wong R., Sagar S. Acupuncture treatment for chemotherapy-induced peripheral neuropathy-a case series. Acupunct Med 2006 Jun, 24(2):87-91.
23. Park J.W., Jeon J.H., Yoon J., Jung T.Y., Kwon K.R., Cho C.K., et al. Effects of sweet bee venom pharmacopuncture treatment for chemotherapy-induced peripheral neuropathy: a case series. Integr Cancer Ther 2012 Jun, 11(2):166-171.
24. Pharmacopuncturology 2008, Korean Pharmacopuncture Institute Academic Committee, Elsevier Korea, Seoul, Korea.
25. Yoon S.Y., Kwon Y.B., Kim H.W., Roh D.H., Seo H.S., Han H.J., et al. Peripheral bee venom's anti-inflammatory effect involves activation of the coeruleospinal pathway and sympathetic preganglionic neurons. Neurosci Res 2007, 59:51-59.
26. Lee J.H., Kwon Y.B., Han H.J., Mar W.C., Lee H.J., Yang I.S., et al. Bee venom pretreatment has both a antinociceptive and anti-inflammatory effect on carageenan-induced inflammation. J Vet Med Sci 2001, 63:251-259.
27. Kwon Y.B., Kim J.H., Yoon J.H., Lee J.D., Han H.J., Mar W.C., et al. The analgesic efficacy of bee venom acupuncture for knee osteoarthritis: a comparative study with needle acupuncture. Am J Chin Med 2001, 29:187-199.
28. An K., Kim Y.S., Kim H.Y., Lee H., Hahm D.H., Lee K.S., et al. Needle-free acupuncture benefits both patients and clinicians. Neurol Res 2010, 32(Suppl. 1):22-26.
29. Green J., McClennon J. Acupuncture: an effective treatment for painful diabetic neuropathy. Diabetic Foot 2006, 6:182.
30. Peter Craig P., Dieppe P., Macintyre S., Michie S., Nazareth I., Petticrew M. Medica. research council: developing and evaluating complex interventions: new guidance. BMJ 2008, 337:a1655.
31. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., Carbone P.P. Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol 1982, 5:649-655.
32. Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer 1981, 47:207-214.
33. Postma T.J., Heimans J.J. Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol 2000, 11:509-513.
34. Cavaletti G., Frigeni B., Lanzani F., Mattavelli L., Susani E., Alberti P., et al. Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer 2010, 46:479-494.
35. Hausheer F.H., Schilsky R.L., Bain S., Berghorn E.J., Lieberman F. Diagnosis, management, and evaluation of chemotherapyinduced peripheral neuropathy. Semin Oncol 2006, 33:15-49.
36. Shimozuma K., Ohashi Y., Takeuchi A., Aranishi T., Morita S., Kuroi K., et al. Feasibility and validity of the patient neurotoxicity questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. Support Care Cancer 2009, 17:1483-1491.
37. Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, et al. Assessment and quantification of taxane-induced neurotoxicity in a phase III randomized trial of breast cancer (AC followed by PAC/DOC vs. PAC/DOC alone): N-SAS BC 02. J Clin Oncol. 2006 ASCO Annual Meeting Proceedings Part I. Vol. 24, No. 18S (June 20 Supplement), 2006: 8523.
38. Takeda and BioNumerik Announce Results of Tavocept™ Phase 3 Trials Focused on Neuropathy Indication Jul. 2006, BioNumerik Pharmaceuticals, Inc. Takeda Pharmaceutical Company Limited, retrieved Jul. 15. 2011, from. http://www.takeda.com/press/article_1257.html.
39. Carlsson A.M. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983, 16:87-101.
40. Grzankowski K., Carney M. Quality of life in ovarian cancer. Cancer Control 2011, 18:52-58.
41. Wenzel L.B., Huang H.Q., Armstrong D.K., Walker J.L., Cella D. Gynecologic oncology group. Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a gynecologic oncology group study. J Clin Oncol 2007, 25:437-443.
42. Cella D.F., Tulsky D.S., Gray G., Sarafian B., Linn E., Bonomi A., et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993, 11:570-579.
43. Choi Y.C., Kwon K.R., Choi S.H. Purification of peptide components including melittin from bee venom using gel filtration chromatography and propionic acid/urea polyacrylamide gel electrophoresis. J Korean Pharmacoacupun Inst 2006, 9:105-112.
44. Kwon K.R., Choi S.H., Cha B.C. Component analysis of sweet BV and clinical trial on antibody titer and allergic reactions. J Korean Pharmacoacupun Inst 2006, 9:79-86.
45. Lee J.S., Lee J.Y., Kwon K.R., Lee H.C. A study on allergic response between bee venom and sweet bee venom pharmacopunture. J Korean Pharmacoacupun Inst 2006, 9:61-77.
46. Yoo H.S., Kim J.S. The effect of sweet bee venom pharmacopuncture (SBVP) on cancer-related pain: a randomized controlled trial and double blinded - pilot study. J Korean Pharmacoacupun Inst 2008, 11:21-29.
47. Moon D.O., Park S.Y., Lee K.J., Heo M.S., Kim K.C., Kim M.O., et al. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol 2007, 7:1092-1101.
48. Kang K.S., Kwon K.R. Experimental studies of validation and stability of sweet bee venom using HPLC. J Korean Pharmacoacupun Inst 2009, 12:33-49.
49. Cheng X. Chinese Acupuncture and Moxibustion 2010, Foreign Languages Press, Beijing. 3rd ed.
50. Marcus A., Kuchera M. Foundations for Integrative Musculoskeletal Medicinean East-west Approach 2005, North Atlantic Books, Berkeley, CA.
51. National Cancer Institute. Common terminology criteria for adverse events (CTCAE). [accessed 05.22.12]. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf.
52. Roh D.H., Kwon Y.B., Kim H.W., Ham T.W., Yoon S.Y., Kang S.Y., et al. Acupoint stimulation with diluted bee venom (apipuncture) alleviates thermal hyperalgesia in a rodent neuropathic pain model: Involvement of spinal alpha2-adrenoceptors. J Pain 2004, 5:297-303.
53. Koyama N., Iwashita N. Melittin-induced neurogenic inflammation is increased through activation of peripheral glutamate receptors. Pain Research 2007, 22:35-41.
54. Chen H.S., Chen J., Sun Y.Y. Contralateral heat hyperalgesia induced by unilaterally intraplantar bee venom injection is produced by central changes: a behavioral study in the conscious rat. Neurosci Lett 2000, 284:45-48.
55. Chen H.S., Chen J. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: effect of systemic MK-801, a non-competitive NMDA receptor antagonist. Eur J Pain 2000, 4:389-401.
56. Chen J., Li H., Luo C., Li Z., Zheng J. Involvement of peripheral NMDA and non-NMDA receptors in development of persistent firing of spinal wide-dynamic-range neurons induced by subcutaneous bee venom injection in the cat. Brain Res 1999, 844:98-105.
57. You H.J., Chen J., Morch C.D., Arendt-Nielsen L. Differential effect of peripheral glutamate (NMDA, non-NMDA) receptor antagonists on bee venom-induced spontaneous nociception and sensitization. Brain Res Bull 2002, 30(58):561-567.